EYPT, CRWV and EOSE Hit Fresh 52-Week Lows
EyePoint Pharmaceuticals, CoreWeave and Eos Energy Enterprises hit fresh 52-week lows Monday. A failed drug trial, debt refinancing concerns and weaker full-year revenue expectations weighed on the stocks; EyePoint fell 85%.
EyePoint Pharmaceuticals (EYPT), CoreWeave (CRWV) and Eos Energy Enterprises (EOSE) reached new 52-week lows Monday. The stocks came under pressure amid a failed drug trial, concerns about debt refinancing and lower expectations for full-year revenue. EyePoint shares plunged 85%. CoreWeave and Eos Energy shares also fell.